BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16107313)

  • 1. Cadherins and catenins in breast cancer.
    Cowin P; Rowlands TM; Hatsell SJ
    Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of HER2-induced endothelial cell retraction.
    Carter WB; Niu G; Ward MD; Small G; Hahn JE; Muffly BJ
    Ann Surg Oncol; 2007 Oct; 14(10):2971-8. PubMed ID: 17593333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherins and the mammary gland.
    Knudsen KA; Wheelock MJ
    J Cell Biochem; 2005 Jun; 95(3):488-96. PubMed ID: 15838893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadherins in development and cancer.
    Stemmler MP
    Mol Biosyst; 2008 Aug; 4(8):835-50. PubMed ID: 18633485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of E-cadherin/catenin complex in laryngeal cancer.
    Mittari E; Charalabopoulos A; Batistatou A; Charalabopoulos K
    Exp Oncol; 2005 Dec; 27(4):257-61. PubMed ID: 16404343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling.
    Derycke LD; Bracke ME
    Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-cadherin role in normal breast development and cancer.
    Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
    Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
    Yuan Z; Wong S; Borrelli A; Chung MA
    Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of cadherins during development and carcinogenesis.
    Peinado H; Portillo F; Cano A
    Int J Dev Biol; 2004; 48(5-6):365-75. PubMed ID: 15349812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherins in neuronal morphogenesis and function.
    Suzuki SC; Takeichi M
    Dev Growth Differ; 2008 Jun; 50 Suppl 1():S119-30. PubMed ID: 18430170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cadherin/catenin complex in malignant melanoma.
    Bonitsis N; Batistatou A; Karantima S; Charalabopoulos K
    Exp Oncol; 2006 Sep; 28(3):187-93. PubMed ID: 17080010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
    Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
    Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of E-cadherin endocytosis by loss of protein phosphatase 2A expression in human breast cancers.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2006 Oct; 349(1):255-60. PubMed ID: 16930554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition.
    Imamichi Y; Menke A
    Cells Tissues Organs; 2007; 185(1-3):180-90. PubMed ID: 17587824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
    Christgen M; Bruchhardt H; Hadamitzky C; Rudolph C; Steinemann D; Gadzicki D; Hasemeier B; Römermann D; Focken T; Krech T; Ballmaier M; Schlegelberger B; Kreipe H; Lehmann U
    J Pathol; 2009 Apr; 217(5):620-32. PubMed ID: 19191266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes.
    Canavese G; Bernardi A; Candelaresi G; Lovadina P; Amerio S; Rossetti V; Rabagliati C; Berardengo E
    Pathol Res Pract; 2007; 203(7):517-23. PubMed ID: 17576040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.